Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement

10 Feb 2016 17:13

RNS Number : 7131O
Income & Growth VCT (the) PLC
10 February 2016
 

 

The Income & Growth VCT plc

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 December 2015

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 31 December 2015. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

 

At 31 December 2015

At 30 September 2015

 

Net assets attributable to shareholders

 

£77,646,538

£75,202,296

 

 

 

Shares in issue

70,693,007

 

70,693,007

 

 

 

 

Net asset value (NAV) per share

 

109.84p 1

106.38p

 

 

 

Cumulative dividends paid to date per share since inception

 

68.50p

 

68.50p

 

 

 

Total return per share since inception (NAV basis)

178.34p

174.88p

 

1 This figure is before deducting the final dividend of 6.00 pence per share for the year ended 30 September 2015 described below. The payment of this dividend on 15 February 2016 will reduce the net asset value per share to 103.84 pence and increase cumulative dividends paid per share since inception of the current share class to 74.50 pence.

 

DIVIDENDS

 

No dividends were paid during the quarter.

 

A final dividend of 6.00 pence per share for the year ended 30 September 2015 was approved by shareholders at the Annual General Meeting of the Company held on 10 February 2016 ("the AGM"). This dividend will be paid on 15 February 2016 to shareholders on the share register on 15 January 2016 and will bring cumulative dividends paid to shareholders in respect of the last five years to 70.00 pence per share.

 

SHARE BUY-BACKS

 

There were no share buy-backs during the quarter.

 

INVESTMENT ACTIVITY

 

New Investments

 

On 2 October 2015, amounts held in existing companies preparing to trade, Knighton Management Limited (£1.55 million) and Tovey Management Limited (£1.50 million), were used to invest in Access IS Limited, a leading provider of data capture and scanning hardware. A further non-qualifying loan of £0.26 million was made to Access IS Limited. The Company's total investment in this company is now £3.31 million.

 

A follow-on loan investment was also made into Racoon International of £0.03 million on 7 October 2015.

 

Realisations

 

On 2 December 2015, the Company realised its investment in Tessella Holdings Limited. The Company received cash proceeds of £4.04 million from the sale and realised a gain over cost of £2.68 million. As part of the transaction, the Company has retained a small investment in Preservica, a data archiving business previously held within Tessella. Total cash proceeds received over the life of this investment were £4.91 million and represent a multiple of 2.8 times original investment cost of £1.75 million.

 

On 8 December 2015, the Company realised its investment in Westway Services Holdings (2014) Limited for cash proceeds of £2.80 million and generated a realised gain of £2.74 million. Total proceeds received over the life of this investment were £3.77 million which is a multiple of 6.7 times the original cost of investment £0.56 million.

 

During January 2016, a total of £0.12 million was received as deferred consideration from earlier disposals of Monsal Holdings, Focus Pharma Holdings, Youngman Group and ATG Media Holdings.

 

Loan Stock Repayments

 

A total of £0.41 million was received in loan stock repayments and premiums during the quarter to 31 December 2015, from Jablite, Leap New Co (Ward Thomas), and Fullfield (Motorclean).

 

After the period end, a further £1.20 million in loan stock repayments and premiums was received from Leap New Co (Ward Thomas) and Fullfield (Motorclean).

REGULATORY DEVELOPMENTS

 

In its Annual Report to shareholders for the year ended 30 September 2015 dated 17 December 2015 ("the Annual Report"), the Board proposed a revised Investment Policy to shareholders in response to the new legislation contained in the UK Finance (no 2) Act 2015, which had become law on 18 November 2015. In summary, the new rules are designed to ensure that VCT investment is used only for growth and development purposes. Investments by VCTs to finance the acquisitions of businesses, such as MBO investments, are no longer permitted. An explanation of the proposed changes to the Investment Policy had been disclosed in the Annual Report. Shareholders approved the revised Investment Policy at the AGM held on 10 February 2016.

 

The Board continues to work with the Investment Adviser and other professional advisers to understand the full implications of the new rules for the type of investments the Company will make in the future. Alongside this process, the Investment Adviser is focusing upon investment opportunities that comply with the new legislation.

 

Please note that all of the information above is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Sarah Penfold, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMGMZNGLGVZM
Date   Source Headline
8th Mar 20241:00 pmRNSTransaction in Own Shares and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
29th Feb 20242:00 pmRNSResult of Annual General Meeting
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
27th Feb 20249:30 amRNSInterim Management Statement
1st Feb 202411:35 amRNSVoting Rights and Capital
22nd Jan 20241:00 pmRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20249:04 amRNSAnnual Financial Report
2nd Jan 20242:30 pmRNSVoting Rights and Capital
1st Dec 20237:00 amRNSTotal Voting Rights
8th Nov 202310:20 amRNSDirector/PDMR Shareholding
8th Nov 202310:15 amRNSIssue of Equity and Total Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20234:00 pmRNSTransaction in Own Shares
25th Sep 202311:00 amRNSDividend Declaration
20th Sep 20233:30 pmRNSInterim Management Statement
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:02 pmRNSTransaction in Own Shares
14th Jun 20237:00 amRNSHalf-year Report
1st Jun 20237:00 amRNSTotal Voting Rights
26th May 20235:15 pmRNSDirector/PDMR Shareholding
26th May 20235:00 pmRNSIssue of Equity and Total Voting Rights
26th May 20234:36 pmRNSNet Asset Value(s)
2nd May 202310:00 amRNSTotal Voting Rights
13th Apr 20231:00 pmRNSDividend Declaration
3rd Apr 20237:00 amRNSTotal Voting Rights
29th Mar 202311:00 amRNSTransaction in Own Shares
27th Mar 20231:00 pmRNSRealisation of investment:Tharstern Group Limited
3rd Mar 20235:04 pmRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTotal Voting Rights
22nd Feb 20233:30 pmRNSInterim Management Statement
22nd Feb 20233:15 pmRNSResult of AGM
7th Feb 20237:01 amRNSDirector/PDMR Shareholding
7th Feb 20237:00 amRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:14 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
11th Jan 20235:34 pmRNSTransaction in Own Shares
19th Dec 20227:00 amRNSAnnual Financial Report
13th Dec 20223:47 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED
5th Dec 20224:00 pmRNSPartial realisation of investment - EOTH Limited
17th Nov 20227:00 amRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.